Pharmafile Logo
Pharmafocus logo
Advanced Search

Cancer

Showing 15 posts of 1067 posts found.

4420456374_64a3d7e6aa

Top Ten most popular articles on Pharmafile.com this week

March 29, 2018
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Ablynx, Cancer, GSK, Hemlibra, MSD, Roche, Sun Pharma, Takeda, brexit, pharma, tecentriq, top ten

As we approach the Easter weekend, we at Pharmafocus hope all of our readers have a great long weekend, if …

News
shutterstock_168864905

InSight Innovations to buy CureTech in $550m deal

March 28, 2018
Research and Development, Sales and Marketing Cancer, CureTech, Insight Innovations, Pfizer, Teva, brain cancer, brain tumour, immunotherapy, israel

Israeli drug firm CureTech is be sold for the third time in four years, this time to InSight Innovations in …

News
cancer-389921_960_720

Lifestyle factors to blame for 38% of cancers

March 23, 2018
Medical Communications Cancer, Cancer Research UK, UK government, biotech, drugs, pharma, pharmaceutical

A new study by Cancer Research UK has found that more than 135,500 cases of cancer every year in the …

News
convert-logo1

Convert secures €13.6m grant to develop targeted chemo for oxygen-deprived tumours

March 9, 2018
Medical Communications, Research and Development Belgium, Cancer, Convert pharma, chemotherapy, pharma

Belgium’s Convert Pharmaceuticals has secured a €13.6 million grant for initial development efforts on a new targeted chemotherapy drug which …

News
samsung_bioepis

Ontruzant launches to become first Herceptin biosimilar available in the UK

March 8, 2018
Sales and Marketing Cancer, Herceptin, MSD, Ontruzant, Roche, Samsung Bioepis, pharma

Ontruzant, the biosimilar version of Herceptin (trastuzumab ) originally developed by Korean firm Samsung Bioepis, has launched for patients in …

News
shutterstock_273326141

Eisai and MSD team up to combine Lenvima and Keytruda in cancer

March 8, 2018
Sales and Marketing Cancer, Eisai, Kidney cancer, Lenvima, MSD, Merck, keytruda, pharma

Pharma heavyweights MSD (Merck) and Eisai have announced they are to join forces to develop and commercialise the latter’s tyrosine …

News

FDA authorises first direct-to-consumer test for BRCA mutations, with caveats

March 6, 2018
Research and Development, Sales and Marketing 23andME, BRCA, Cancer, FDA, breast cancer, ovarian cancer, pharma

The FDA has given its authorisation to the first ever direct-to-consumer (DTC) test to identify three BRCA gene mutations which …

News
shutterstock

Blood test could predict treatment effectiveness months earlier in breast cancer

March 6, 2018
Manufacturing and Production, Research and Development Cancer, ICR, Institute of Cancer Research, Royal Marsden NHS Foundation Trust, breast cancer, palbociclib, pharma

A team of scientists at The Institute of Cancer Research in London and The Royal Marsden NHS Foundation Trust have …

News
celgene_1_02

Celgene strikes $101m partnership in oncology, neurodegenerative and inflammatory

March 5, 2018
Research and Development, Sales and Marketing Cancer, Celgene, Vividion, inflammatory, neurodegenerative, oncology, pharma

Celgene has inked a new multi-year partnership with biotech firm Vividion Therapeutics to leverage the latter’s proteomics and chemistry platforms …

News
mri_credit_-_ptrump16

NHS trials “world-leading” initiative to cut prostate cancer diagnoses to just days

March 5, 2018
Research and Development, Sales and Marketing Cancer, MRI, NHS, pharma, prostate cancer

The NHS has revealed plans to cut the average diagnosis times for prostate cancer from six weeks to less than …

News

FDA expands indication of Lilly’s Verzenio in advanced breast cancer

February 27, 2018
Manufacturing and Production, Sales and Marketing Cancer, Eli Lilly, FDA, Verzenio, breast cancer, pharma

Eli Lilly is celebrating the news that its cyclin-dependent kinase (CDK) 4 & 6 inhibitor Verzenio (ademaciclib) has received approval …

News

NICE rejects Eisai’s Halaven in earlier setting for metastatic breast cancer

February 22, 2018
Sales and Marketing Brest cancer, Cancer, Eisai, Halaven, NICE, pharma

NICE has published its decision not to recommend Eisai’s Halaven (eribulin) in the treatment of locally advanced or metastatic breast …

News
merckincweb

MSD poised to acquire viral immuno-oncology firm Viralytics for $394m

February 21, 2018
Research and Development, Sales and Marketing Cancer, MSD, Merck, Viralytics, acquisition, keytruda, oncology, pharma

MSD, known as Merck in the US, has announced it is to buy Australian viral immuno-oncology firm Viralytics for $394 …

News

NICE recommends thyroid cancer drug trio for NHS use

February 20, 2018
Manufacturing and Production, Sales and Marketing Bayer, Cancer, Cometriq, Eisai, Lenvima, NICE, Nexavar, ipsen, pharma, thyroid cancer

NICE has announced its decision to recommend that three separate treatments for thyroid cancer should be made available for use …

News
img_9530_resized

Patient experience: Living with multiple myeloma

February 19, 2018
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Cancer, feature, mutiple myeloma, patient experience, pharma

Pharmafocus talks to John Ellwood about the challenges of being diagnosed with multiple myeloma and how having a strong support …

Feature
The Gateway to Local Adoption Series

Latest content

Just – Evotec given Gates Foundation grant to increase global biotherapeutics access

January 8, 2026

Johnson & Johnson submits robotic surgical system for De Novo classification

January 8, 2026

EA Pharma announces phase 3 trial for new schizophrenia treatment in Japan

January 7, 2026

Eleva appoints Erich Rajkovic as Chief Business Officer

January 7, 2026

MedPharm announces US FDA inspection of North Carolina manufacturing facility

January 6, 2026